SCHEMBL20535104

SCHEMBL20535104

CCCCCCCCC(/C=C/CCCCCCC(=O)O)CO

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.66
PPARG P37231 5/20 0.63
TERT O14746 3/20 0.63
PTPN1 P18031 3/20 0.63
PPARD Q03181 3/20 0.63
PPARA Q07869 3/20 0.63
MAPT P10636 2/20 0.63
BLM P54132 2/20 0.63
HSD17B10 Q99714 2/20 0.63
FABP4 P15090 2/20 0.63
F7 P08709 2/20 0.63
F3 P13726 2/20 0.63
GMNN O75496 1/20 0.63
USP2 O75604 1/20 0.63
LMNA P02545 1/20 0.63
CYP1A2 P05177 1/20 0.63
POLB P06746 1/20 0.63
CYP2C9 P11712 1/20 0.63
ALOX15 P16050 1/20 0.63
APEX1 P27695 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20534392 1.00 ALOX5 (0.66) ALOX5PPARGTERTPTPN1PPARD
SCHEMBL21708270 1.00 ALOX5 (0.66) ALOX5PPARGTERTPTPN1PPARD
SCHEMBL21708352 1.00 ALOX5 (0.66) ALOX5PPARGTERTPTPN1PPARD
SCHEMBL28863748 1.00 ALOX5 (0.66) ALOX5PPARGTERTPTPN1PPARD
SCHEMBL8661531 0.92 PPARG (0.69) PPARGTERTPTPN1PPARDPPARA
SCHEMBL3211982 0.92 PPARG (0.69) PPARGTERTPTPN1PPARDPPARA
SCHEMBL15746818 0.92 PPARG (0.69) PPARGTERTPTPN1PPARDPPARA
SCHEMBL8661080 0.92 PPARG (0.69) PPARGTERTPTPN1PPARDPPARA
SCHEMBL15746809 0.92 PPARG (0.69) PPARGTERTPTPN1PPARDPPARA
SCHEMBL28972677 0.92 PPARG (0.69) PPARGTERTPTPN1PPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3913039-B1 BLEND OF ESTER COMPOUNDS KLUEBER LUBRICATION MUENCHEN SE & CO KG (DE) 2024-01-31 EP disclosed
US-11795134-B2 Ester compounds, method for the production thereof and use thereof KLÜBER LUBRICATION MÜNCHEN SE & CO. KG (DE) 2023-10-24 US disclosed
US-11795134-B2 Ester compounds, method for the production thereof and use thereof KLÜBER LUBRICATION MÜNCHEN SE & CO. KG (DE) 2023-10-24 US disclosed
EP-3609988-B1 USE OF ESTER COMPOSITION KLUEBER LUBRICATION MUENCHEN SE & CO KG (DE) 2023-06-07 EP disclosed
CN-110431218-B Novel ester compound, process for producing the same, and use thereof 慕尼黑克吕伯尔润滑器股份两合公司 2022-09-13 CN disclosed
EP-3913039-A1 ESTER COMPOUNDS, METHOD FOR THEIR PREPARATION AND THEIR USE Klüber Lubrication München SE & Co. KG (DE) 2021-11-24 EP disclosed
US-20210061750-A1 Novel Ester Compounds, Method for the Production Thereof and Use Thereof KLUBER LUBRICATION MUNCHEN SE & Co. KG (DE) 2021-03-04 US disclosed
US-10829436-B2 Ester compounds, method for the production thereof and use thereof KLÜBER LUBRICATION MÜNCHEN SE & CO. KG (DE) 2020-11-10 US disclosed
US-20200140370-A1 Novel Ester Compounds, Method for the Production Thereof and Use Thereof UNIVERSITÄTSSTR BIELEFELD (DE) 2020-05-07 US disclosed
EP-3609988-A1 NOVEL ESTER COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF Klüber Lubrication München SE & Co. KG (DE) 2020-02-19 EP disclosed
WO-2018188803-A1 NOVEL ESTER COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF KLÜBER LUBRICATION MÜNCHEN SE & CO. KG (DE) 2018-10-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10829436-B2 Ester compounds, method for the production thereof and use thereof CYP46A1, CYP51A1, CEL ALOX5 171/4885PPARG 639/4885TERT 1249/4885
US-11795134-B2 Ester compounds, method for the production thereof and use thereof CYP46A1, CYP17A1, CYP51A1 ALOX5 197/4885PPARG 681/4885TERT 1024/4885
US-20210061750-A1 Novel Ester Compounds, Method for the Production Thereof and Use Thereof CYP46A1, CEL, CYP51A1 ALOX5 243/4885PPARG 1094/4885TERT 1549/4885
US-20200140370-A1 Novel Ester Compounds, Method for the Production Thereof and Use Thereof CYP46A1, CYP51A1, CEL ALOX5 243/4885PPARG 1109/4885TERT 1796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.